BridgeMD
Evaluation of the effect of tacrolimus on carbohydrate metabolism in pre-renal transplantation dialysis patients
EU CTIS ID: 2024-514072-40-00
What this study is testing
Determine the proportion of hemodialysis patients who change their glycemic profile on Tacrolimus
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- ≥ 18 years old
- Patient eligible for a kidney transplant at Nantes University Hospital
- Hemodialysis patient in one of the participating centers
- Patient able to understand the proposed protocol and having given free and informed consent
- Patient with social security coverage
You likely can't join if
- Personal history of treated or untreated diabetes
- Patients under guardianship, curatorship, legal protection, or deprived of liberty
- Pregnant, breast-feeding or premenopausal women refusing contraception
- Temporary contraindication for carcinological reasons
- Immunosuppressive treatment in the 6 months prior to inclusion
- Macrolide allergies
See the full eligibility criteria
- ≥ 18 years old
- Patient eligible for a kidney transplant at Nantes University Hospital
- Hemodialysis patient in one of the participating centers
- Patient able to understand the proposed protocol and having given free and informed consent
- Patient with social security coverage
- Personal history of treated or untreated diabetes
- Patients under guardianship, curatorship, legal protection, or deprived of liberty
- Pregnant, breast-feeding or premenopausal women refusing contraception
- Temporary contraindication for carcinological reasons
- Immunosuppressive treatment in the 6 months prior to inclusion
- Macrolide allergies
- Hypersensitivity to excipients in the composition of tacrolimus
- Intolerance to the HGPO test
- Infectious outbreak
- Liver failure
- Intercurrent infectious pathology
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.